ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Operating cash flow 2018–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.6MFY2025 · since FY2018: -$14.1M → -$5.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.6M | +95.0% |
| FY2024 | -$112.2M | +54.6% |
| FY2023 | -$247.1M | +4.1% |
| FY2022 | -$257.7M | -47.6% |
| FY2021 | -$174.6M | -54.5% |
| FY2020 | -$113.0M | -163.9% |
| FY2019 | -$42.8M | -204.1% |
| FY2018 | -$14.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARQT financial trends
ARQT RevenueARQT Net incomeARQT Net marginARQT Gross profitARQT Gross marginARQT Operating incomeARQT Operating marginARQT Free cash flowARQT Capital expendituresARQT Return on equityARQT Stock buybacksARQT Dividends paidARQT Total assetsARQT Total liabilitiesARQT Shareholders’ equityARQT overview →